盈康生命(300143) - 300143盈康生命投资者关系管理信息20251202

Group 1: Hospital Overview - Changsha Kexin Tumor Hospital officially opened in September 2015, approved by the Hunan Health Commission, and is a tertiary specialized cancer hospital [1][2] - The hospital occupies an area of 27 acres with an initial capacity of 420 beds, currently operating at full capacity, and employs over 500 staff [2] - It has been recognized with multiple awards, including "Excellent Department in Improving Medical Services" and "Top 100 Service Enterprises in Xiangjiang New Area" [2] Group 2: Differentiation and Service Model - The hospital focuses on a patient-centered service system, implementing a "Ten Fears and Ten Promises" service commitment mechanism to enhance patient experience [3] - The "Medical Square" service model integrates various professional resources to provide comprehensive, one-stop services, contributing to a sustainable brand reputation [3] Group 3: Technological and Equipment Advantages - In the first nine months of 2025, the hospital performed over 7,000 minimally invasive surgeries, with an 8% year-on-year increase [4] - The introduction of advanced DSA equipment increased monthly surgical volume from 465.5 to 788.4, a growth rate of 69% [5] - New radiation therapy equipment, such as TOMO-C, is expected to enhance precision treatment capabilities [5] Group 4: Future Development Plans - The hospital is preparing for a second phase of construction, aiming to add over 400 beds to expand medical service capacity [6] - The goal is to establish Changsha Kexin as a leading tumor specialized hospital in Central China, enhancing service capabilities and brand position [6] Group 5: Long-term Strategic Planning - The company embraces healthcare reform, aiming to provide timely detection, precise treatment, and rapid recovery through differentiated medical solutions [7] - The resource allocation strategy follows a "3/3/3" model, focusing on social healthcare, personalized services, and continuous health management for outpatients [8] - The company is transitioning from a traditional medical group to a health management technology company, leveraging AI to improve service efficiency and quality [8]